Most people who get COVID-19 in 2025 recover at home with rest and over-the-counter medications. For those at higher risk of severe illness, prescription antivirals can significantly reduce the chance of hospitalization, but they need to be started within the first few days of symptoms. Knowing which category you fall into, and acting quickly, is the most important part of treatment.
Start With a Test, and Time It Right
Home rapid antigen tests still work against current variants, but their accuracy depends heavily on timing. The highest rate of positive results on antigen tests occurs about three days after symptoms begin. If you have a fever, tests perform even better, catching roughly 80% of infections within two days of symptom onset. Testing before you have symptoms is far less reliable, with sensitivity dropping to just 18% compared to lab-based PCR tests.
If your first rapid test is negative but you feel sick, test again in 24 to 48 hours. A single negative result early in the illness doesn’t rule out COVID, especially if you’re only experiencing mild congestion or fatigue without fever.
Home Treatment for Mild Illness
If you’re generally healthy and your symptoms are mild, home care is straightforward. Acetaminophen or ibuprofen will help with fever, headaches, and body aches. Stay well hydrated, prioritize sleep, and rest as much as your body asks you to. There’s no special diet or supplement regimen proven to speed recovery. The NIH has reviewed vitamin C, vitamin D, and zinc specifically for COVID-19 and found insufficient evidence that any of them help prevent or treat the illness. High-dose zinc supplements are specifically recommended against.
Most mild cases resolve within a week or two. During that time, stay home and away from others, including household members who aren’t sick, while you have respiratory symptoms.
Who Qualifies for Antiviral Treatment
Antivirals are recommended for people with mild or moderate COVID who have at least one risk factor for severe illness. The goal is to prevent the kind of progression that leads to hospitalization or death. You’re considered higher risk if you:
- Are over 65, with risk climbing substantially above age 75
- Are unvaccinated or not up to date on COVID vaccines
- Have chronic medical conditions, especially multiple ones (heart disease, diabetes, obesity, lung disease, kidney disease)
- Are immunocompromised or taking medications that suppress your immune system, such as chemotherapy
If any of these apply to you, contact your doctor or a telehealth provider as soon as you test positive. The treatment window is narrow.
Antiviral Options in 2025
Paxlovid (nirmatrelvir-ritonavir) remains the first-line treatment. It’s an oral medication taken for five days, and it must be started within five days of your first symptoms. It’s approved for adults and children 12 and older who weigh at least 88 pounds. The main limitation is drug interactions: Paxlovid affects how your body processes many common medications, including certain blood thinners, cholesterol drugs, and heart medications. Your prescriber will review your medication list before writing the prescription, and dosing may need adjustment if you have kidney problems.
If Paxlovid isn’t an option for you, remdesivir is an alternative. It’s given as an intravenous infusion over 30 to 120 minutes on three consecutive days, so it requires visits to a clinic or infusion center. It can be started within seven days of symptom onset, giving a slightly longer window. It’s approved for adults and children as young as 28 days old.
Molnupiravir is a third option, reserved for situations where neither Paxlovid nor remdesivir is accessible or appropriate. Like Paxlovid, it’s a five-day oral course that must start within five days of symptoms. One important caveat: it carries reproductive risks and is not recommended during pregnancy. Both partners should use contraception during and shortly after treatment.
Monoclonal Antibodies Are Mostly Gone
If you remember monoclonal antibody infusions from earlier in the pandemic, nearly all of them have been pulled. The FDA revoked authorizations for bebtelovimab, sotrovimab, REGEN-COV, Evusheld, and the bamlanivimab-etesevimab combination because the virus mutated past them. One product, pemivibart (Pemgarda), received emergency authorization in early 2024 for prevention in immunocompromised people, but its effectiveness depends on which variants are circulating at any given time. For most people, antivirals are now the treatment path.
Emergency Warning Signs
Most COVID infections stay mild, but some worsen quickly. Call 911 or go to an emergency room if you experience:
- Difficulty breathing or shortness of breath that doesn’t improve with rest
- Persistent chest pain or pressure
- New confusion or difficulty thinking clearly
- Inability to stay awake or difficulty being roused from sleep
- Color changes in the lips, nail beds, or skin, appearing pale, gray, or blue
These signs can appear at any point during the illness but most commonly develop in the second week, around days 7 through 10.
Vaccines for Fall 2025
The FDA has directed manufacturers to update COVID vaccines for fall 2025 to target the JN.1 lineage, preferentially using the LP.8.1 strain. This reflects the variants currently circulating and represents a shift from previous formulations. Staying up to date on vaccination is one of the strongest ways to reduce your risk of severe illness if you do get infected, and being unvaccinated is itself considered a risk factor for hospitalization.
If Symptoms Linger for Weeks
Some people develop long COVID, where symptoms persist or appear weeks after the initial infection. The most common complaints include crushing fatigue, brain fog, shortness of breath, and joint or muscle pain. A hallmark feature is post-exertional malaise, where even minor physical or mental effort causes symptoms to flare 12 to 48 hours later, sometimes lasting days or weeks.
There is no single cure for long COVID in 2025. Treatment is symptom-focused: identifying the problems that affect your daily life most and managing them with approaches borrowed from similar conditions like chronic fatigue syndrome, fibromyalgia, and dysautonomia. This often involves a structured rehabilitation plan, pacing strategies to avoid triggering post-exertional crashes, and optimizing any underlying health conditions that may be compounding the problem. Keeping a symptom diary to track patterns and triggers can help both you and your care team make better decisions over time.